References
Lehmann K, Eshmuminov D, Slankamenac K, et al. Where oncologic and surgical complication scoring systems collide: time for a new consensus for CRS/HIPEC. World J Surg. 2016;40:1075–81.
Slankamenac K, Graf R, Barkun J, et al. The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg. 2013;258:1–7.
Slankamenac K, Nederlof N, Pessaux P, et al. The comprehensive complication index: a novel and more sensitive end point for assessing outcome and reducing sample size in randomized controlled trials. Ann Surg. 2014;260:757–62.
Nederlof N, Slaman AE, van Hagen P, et al. Using the Comprehensive Complication Index to assess the impact of neoadjuvant chemoradiotherapy on complication severity after esophagectomy for cancer. Ann Surg Oncol. 2016;23(12):3964–71.
Dumitra S, O’Leary M, Raoof M, et al. The Comprehensive Complication Index: a new measure of the burden of complications after hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2018;25:688–93.
Choudry MHA, Shuai Y, Jones HL, et al. Postoperative complications independently predict cancer-related survival in peritoneal malignancies. Ann Surg Oncol. 2018;25(13):3950–9.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
The authors have no conflicts of interest to disclose.
Additional information
ASO Author Reflections offer a brief invited commentary on the article, “The Comprehensive Complication Index: A New Measure of the Burden of Complications After Hyperthermic Intraperitoneal Chemotherapy”, Ann Surg Oncol. 2018;25:688–93.
Rights and permissions
About this article
Cite this article
Dumitra, S., Lee, B. ASO Author Reflections: A Novel Tool to Assess and Describe HIPEC Complications. Ann Surg Oncol 26 (Suppl 3), 557–558 (2019). https://doi.org/10.1245/s10434-018-7053-x
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-018-7053-x